| | mg | |
Bosentan | Intravenous infusion (5 min) | 10, 50, 250, 500, or 750 | Weber et al. (1996) |
Bosentan | Intravenous infusion (15 min) | 250 | Weber et al. (1999b) |
Bosentan | Tablet after high-fat meal | 500 | U.S. Food and Drug Administration (2001) |
Bosentan | Tablet after high-fat meal | 125 | Dingemanse et al. (2002) |
Bosentan | Tablet | 500 | Weber et al. (1999c) |
Bosentan | Tablet | 62.5 | van Giersbergen et al. (2002b) |
Bosentan (twice daily) and tadalafil (once daily) | Tablet | Bosentan: 125; tadalafil: 40 | Wrishko et al. (2008) |
Bosentan (twice daily) and warfarin (once on day 6) | Tablet | Bosentan: 500; racemic mixture of warfarin: 26 | Weber et al. (1999a) |